Progestogen only contraception in women with congenital heart disease
Baró-Mariné, Francesc (Hospital Universitari Vall d'Hebron)
Pijuan-Domènech, Antonia (Hospital Universitari Vall d'Hebron)
Goya, M (Hospital Universitari Vall d'Hebron)
Suárez-Edo, Elena (Hospital Universitari Vall d'Hebron)
Miranda, Berta (Hospital Universitari Vall d'Hebron)
Dos Subira, Laura (Hospital Universitari Vall d'Hebron)
Pancorbo, Maria Luisa (Hospital Universitari Vall d'Hebron)
Ferreira-Gonzalez, Ignacio (Hospital Universitari Vall d'Hebron)
Carreras Moratonas, Elena (Hospital Universitari Vall d'Hebron)
Universitat Autònoma de Barcelona

Date:	2024
Abstract:	Background: There is little information of progestogen-only contraceptives in patients with congenital heart disease (CHD) on the long-term. Objective: To evaluate the use of contraception in patients with CHD. We studied both short-acting reversible contraceptives (SARCs), oral progestin-only pills (POPs) and long-acting reversible contraceptives (LARCs): intrauterine devices (IUD-IPs) and subdermal implants both impregnated with progestogens (SI-IPs). Study design: Retrospective study of all women attending the preconception clinic. Contraceptive methods were classified in three TIERs of effectiveness before and after consultation. ESC classification regarding pregnancy risk, WHOMEC classification for combined oral contraceptive safety was collected. Results: Six hundred and fifty-three patients. A significant proportion of them switched from TIER 3 to TIER 2 or 1 (p < . 001) after consultation. One hundred and ninety-nine patients used POPs, 53 underwent IUD-IPs implantation and 36 SI-IPs, mean duration was 58 ± 8, 59 ± 8 and 53 ± 38 months, respectively. Conclusions: Because of their safety and efficacy, IUD-IPs and SI-IPs should be considered as first-line contraception in patients with CHD.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Congenital heart disease ; LARCs methods (long-acting reversible contraceptive) ; SARCs methods (short-acting reversible contraceptive) ; Progesterone only contraception
Published in:	Journal of Obstetrics and Gynaecology, Vol. 44 Núm. 1 (2024) , p. 2320296, ISSN 1364-6893

DOI: 10.1080/01443615.2024.2320296
PMID: 38466189

9 p, 1.2 MB

The record appears in these collections:
Articles > Research articles
Articles > Published articles